Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Inge Spiller"'
Publikováno v:
Zeitschrift für Rheumatologie. 79:729-736
Zusammenfassung Hintergrund Der oft langsame Beginn einer axialen Spondyloarthritis (axSpA), die initial zum Teil wenig spezifischen Symptome (Rückenschmerzen), aber auch begrenzte Ressourcen und die damit verbundenen Verzögerungen in der rheumatol
Autor:
Laura Spiller, Imke Redeker, B. Muche, J. Rademacher, Valeria Rios Rodriguez, Fabian Proft, Denis Poddubnyy, A. K. Weber, S. Lüders, Joachim Sieper, Inge Spiller, Mikhail Protopopov
Publikováno v:
Joint Bone Spine. 87:69-73
To evaluate the performance of the Ankylosing Spondylitis Disease Activity Score based on a validated quick quantitative C-reactive protein assay (ASDAS-qCRP) as compared to ASDAS based on a routine lab CRP assay (ASDAS-CRP) and ASDAS based on erythr
Autor:
Laura Spiller, V. Rios Rodriguez, J. Sieper, Inge Spiller, Fabian Proft, A. K. Weber, Mikhail Protopopov, Denis Poddubnyy, S. Lüders, M. Schmidt, J. Rademacher, B. Muche
Publikováno v:
FRIDAY, 15 JUNE 2018.
Background The Ankylosing Spondylitis Disease Activity Score (ASDAS) is a composite index to assess disease activity in patients with axial spondyloarthritis (axSpA). According to the treat-to-target (T2T) recommendations for SpA, and the ASAS/EULAR
Autor:
J. Rademacher, J. Sieper, B. Muche, Laura Spiller, Fabian Proft, Denis Poddubnyy, Matthew C. Schmidt, V. Rios Rodriguez, S. Lüders, A. K. Weber, Inge Spiller, Mikhail Protopopov
Publikováno v:
THURSDAY, 14 JUNE 2018.
Autor:
Janis L Vahldiek, Inge Spiller, Denis Poddubnyy, H. Brandt, Joachim Sieper, Martin Rudwaleit, In-Ho Song
Publikováno v:
Annals of the Rheumatic Diseases. 71:1998-2001
This study was aimed at investigating the frequencies of non-radiographic axial spondyloarthritis (nr-axSpA) and ankylosing spondylitis (AS) diagnoses and their ratios in relation to symptom duration in patients referred because of chronic back pain
Publikováno v:
Annals of the Rheumatic Diseases. 66:1479-1484
Ankylosing spondylitis (AS) and its early form account for up to 5% of all patients with chronic back pain. Interest has recently focused on shortening the delay of 5-10 years between the appearance of first symptoms and the diagnosis of AS, particul
Autor:
Andreas Radbruch, Zhinan Yin, Joachim Sieper, Stefanie Siegert, Martin Rudwaleit, Jürgen Braun, Lanzhen Liu, Inge Spiller
Publikováno v:
Arthritis & Rheumatism. 42:2039-2044
Objective To determine Th1 and Th2 cytokine production in patients with reactive arthritis (ReA) in relation to disease outcome and in comparison with rheumatoid arthritis (RA). Methods Secretion of tumor necrosis factor α (TNFα), interferon-γ, in
Publikováno v:
Annals of the Rheumatic Diseases. 75:578.3-579
Background Inflammatory back pain (IBP) as a symptom has been shown to perform effectively for selecting patients in primary care/orthopaedic settings for referral of chronic back pain patients to the rheumatologist for further diagnostic work-up. IB
Autor:
Joachim Sieper, Denis Poddubnyy, Joachim Listing, Janis L Vahldiek, Martin Rudwaleit, Beate Buss, Inge Spiller
Publikováno v:
The Journal of rheumatology. 38(11)
Objective.To evaluate 2 referral strategies for axial spondyloarthritis (SpA) in patients with chronic low back pain at the primary care level.Methods.Referral physicians (n = 259) were randomly assigned to either Strategy 1 or Strategy 2 in order to
Autor:
Heiner, Appel, Rebecca, Scheer, Hildrun, Haibel, Peihua, Wu, Inge, Spiller, Henning, Brandt, In-Ho, Song, Martin, Rudwaleit, Andreas, Thiel, Jochen, Sieper
Publikováno v:
The Journal of rheumatology. 34(11)
Anti-tumor necrosis factor-alpha (TNF-alpha) therapy can induce reactivation of tuberculosis and an increase of other infections in patients with ankylosing spondylitis (AS). This raises the question if an alteration of T cell function can be detecte